Neogenomics (NEO) Accounts Payables (2010 - 2026)

Neogenomics has reported Accounts Payables for 17 years, with the latest figure at $25.9 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 59.76% year-over-year to $25.9 million; the trailing twelve-month figure through Mar 2026 stood at $25.9 million (up 59.76% YoY), and the FY2025 full-year result was $23.1 million, up 6.86% from the prior year.
• Accounts Payables for Q1 2026 stood at $25.9 million, up from $23.1 million in the prior quarter.
• The five-year high for Accounts Payables was $27.5 million in Q2 2025, with the low at $13.7 million in Q3 2022.
• Historically, Accounts Payables has averaged $19.9 million across 5 years, with a median of $20.3 million in 2023.
• Annual changes were most pronounced in 2022 — Accounts Payables slumped 51.96% — and 2025, when it soared 59.97%.
• Neogenomics' Accounts Payables stood at $20.5 million in 2022, then decreased by 0.86% to $20.3 million in 2023, then gained by 6.26% to $21.6 million in 2024, then rose by 6.86% to $23.1 million in 2025, then grew by 12.16% to $25.9 million in 2026.
• The last three Accounts Payables figures came in at $25.9 million (Q1 2026), $23.1 million (Q4 2025), and $22.6 million (Q3 2025), per Business Quant data.